Acarix A/S - Asset Resilience Ratio

Latest as of December 2025: 37.81%

Acarix A/S (ACARIX) has an Asset Resilience Ratio of 37.81% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr18.27 Million

≈ $1.97 Million USD Cash + Short-term Investments

Total Assets

Skr48.33 Million

≈ $5.20 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Acarix A/S's Asset Resilience Ratio has changed over time. Check how strategically is Acarix A/S's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Acarix A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Acarix A/S (ACARIX) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr18.27 Million	37.81%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr18.27 Million	37.81%

Asset Resilience Insights

Very High Liquidity: Acarix A/S maintains exceptional liquid asset reserves at 37.81% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Acarix A/S Industry Peers by Asset Resilience Ratio

Compare Acarix A/S's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Acarix A/S (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Acarix A/S.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.19%	Skr152.00K ≈ $16.36K	Skr80.76 Million ≈ $8.69 Million	-0.05pp
2023-12-31	0.23%	Skr147.00K ≈ $15.82K	Skr62.88 Million ≈ $6.77 Million	-16.04pp
2022-12-31	16.28%	Skr11.31 Million ≈ $1.22 Million	Skr69.48 Million ≈ $7.48 Million	+2.79pp
2021-12-31	13.49%	Skr16.00 Million ≈ $1.72 Million	Skr118.60 Million ≈ $12.76 Million	+13.27pp
2020-12-31	0.22%	Skr195.00K ≈ $20.99K	Skr89.95 Million ≈ $9.68 Million	-0.07pp
2019-12-31	0.28%	Skr234.00K ≈ $25.18K	Skr82.98 Million ≈ $8.93 Million	-68.19pp
2018-12-31	68.48%	Skr65.19 Million ≈ $7.02 Million	Skr95.20 Million ≈ $10.24 Million	-8.79pp
2017-12-31	77.27%	Skr103.58 Million ≈ $11.15 Million	Skr134.06 Million ≈ $14.43 Million	-6.97pp
2016-12-31	84.24%	Skr145.97 Million ≈ $15.71 Million	Skr173.29 Million ≈ $18.65 Million	+83.89pp
2015-12-31	0.35%	Skr54.00K ≈ $5.81K	Skr15.58 Million ≈ $1.68 Million	--

pp = percentage points

About Acarix A/S

ST:ACARIX Sweden Medical Devices

Market Cap

$31.27 Million

Skr290.59 Million SEK

Market Cap Rank

#23567 Global

#459 in Sweden

Share Price

Skr0.25

Change (1 day)

-0.99%

52-Week Range

Skr0.24 - Skr0.41

All Time High

Skr20.62